Finnrick, an independent testing programme, publishes 49 assays for Shanghai OuDaXin New Material Technology Center: 36 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 13 did not. Most recent assay 23 Apr 2026.
Shanghai OuDaXin New Material Technology Center operates from Shanghai, listed by Finnrick as "Trading", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/shanghai-oudaxin-new-material-technology-center.
Finnrick-tested with very poor results. Tested across 3 peptide products with 45 total samples.
Shanghai OuDaXin New Material Technology Center is listed as active. Finnrick Grade E. Finnrick avg score: 5.6/10 across 45 samples (3 products). Poor quality detected in testing. Use with extreme caution.
Shanghai OuDaXin New Material Technology Center holds independent lab grade E, assigned across 45 graded samples, average score 5.6/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Shanghai OuDaXin New Material Technology Center, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 24 | 19 passed, 5 failed |
| Retatrutide | 13 | 9 passed, 4 failed |
| Tesamorelin | 8 | 5 passed, 3 failed |
| Ipamorelin | 4 | 3 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | E (45 samples) |
| Average grader score | 5.6/10 |
| Vendor type | Research-use supplier |
Shanghai OuDaXin New Material Technology Center is listed as active and we hold 49 Finnrick assays (36 passing, 13 failing its purity threshold); an independent lab grade of E. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 49 assays for Shanghai OuDaXin New Material Technology Center: 36 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 13 did not. Most recent assay 23 Apr 2026.
Similar vendors: Modern Aminos, Shanxi Qianyecao Biotech QYC, Mix Peptides, Xian Yihang Technology, Zhuoyue Biotechnology, Haikou Mingheng Biotechnology, Alimo Peptide, Peptides For Sale.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Shanghai Sigma Audley SSA Peptides Review, Shanghai Wibson Biotechnology WBS Peptides Review, Shanghai Yu Si Medical Technology Co Peptides Review.